Literature DB >> 15186779

Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer.

Manfred Kraus1, Marat B Alimzhanov, Nikolaus Rajewsky, Klaus Rajewsky.   

Abstract

We previously showed that type I interferon-induced, Cre-mediated ablation of surface BCR expression in mature B cells through Ig-heavy chain deletion results in apoptosis of these cells. This led to the hypothesis that survival signals from the BCR are vital for mature B cells. Here, we test two critical assumptions of this model. First, we demonstrate loss of mature B cells upon induced mutation of a signaling module of the BCR, not precluding BCR surface expression. Second, we show that the cells are also lost upon BCR inactivation in the absence of an exogenous inducer like interferon, excluding that cell death depends on previous cellular activation by the latter. Kinetic data demonstrate that BCR-less mature B cells have a severely reduced lifespan, with a half-life of 3-6 days. Together these results establish that BCR signaling is required to keep resting mature B cells alive in vivo.

Mesh:

Substances:

Year:  2004        PMID: 15186779     DOI: 10.1016/j.cell.2004.05.014

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  237 in total

1.  Cellular competition independent of BAFF/B lymphocyte stimulator results in low frequency of an autoreactive clonotype in mature polyclonal B cell compartments.

Authors:  Neda Nikbakht; Thi-Sau Migone; Chris P Ward; Tim Manser
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

Review 2.  Regulation of mucosal IgA responses: lessons from primary immunodeficiencies.

Authors:  Andrea Cerutti; Montserrat Cols; Maurizio Gentile; Linda Cassis; Carolina M Barra; Bing He; Irene Puga; Kang Chen
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

3.  Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells.

Authors:  Ildiko Györy; Sören Boller; Robert Nechanitzky; Elizabeth Mandel; Sebastian Pott; Edison Liu; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2012-03-19       Impact factor: 11.361

Review 4.  The future of B-cell lymphoma therapy: the B-cell receptor and its downstream pathways.

Authors:  Vaishalee P Kenkre; Brad S Kahl
Journal:  Curr Hematol Malig Rep       Date:  2012-09       Impact factor: 3.952

Review 5.  Oncogenic activation of NF-kappaB.

Authors:  Louis M Staudt
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

6.  Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas.

Authors:  Monica Gostissa; Julia M Bianco; Daniel J Malkin; Jeffery L Kutok; Scott J Rodig; Herbert C Morse; Craig H Bassing; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

7.  Specific recruitment of protein kinase A to the immunoglobulin locus regulates class-switch recombination.

Authors:  Bao Q Vuong; Mieun Lee; Shaheen Kabir; Cristina Irimia; Stephania Macchiarulo; G Stanley McKnight; Jayanta Chaudhuri
Journal:  Nat Immunol       Date:  2009-02-22       Impact factor: 25.606

8.  B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.

Authors:  Diana Cozma; Duonan Yu; Suchita Hodawadekar; Anna Azvolinsky; Shannon Grande; John W Tobias; Michele H Metzgar; Jennifer Paterson; Jan Erikson; Teresa Marafioti; John G Monroe; Michael L Atchison; Andrei Thomas-Tikhonenko
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

9.  The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibition.

Authors:  Gabriele Varano; Simon Raffel; Martina Sormani; Federica Zanardi; Silvia Lonardi; Christin Zasada; Laura Perucho; Valentina Petrocelli; Andrea Haake; Albert K Lee; Mattia Bugatti; Ulrike Paul; Eelco Van Anken; Laura Pasqualucci; Raul Rabadan; Reiner Siebert; Stefan Kempa; Maurilio Ponzoni; Fabio Facchetti; Klaus Rajewsky; Stefano Casola
Journal:  Nature       Date:  2017-05-31       Impact factor: 49.962

Review 10.  Targeting the B-cell receptor signaling pathway in B lymphoid malignancies.

Authors:  Maike Buchner; Markus Müschen
Journal:  Curr Opin Hematol       Date:  2014-07       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.